BioSpace News Archive

Accelerating cell and gene therapy opportunities for patients by advancing access to knowledge and leveraging experience for sponsors to increase program success.

Oxford Immunotec Global PLC announced that it has been selected to provide T cell testing to the UK Vaccines Taskforce, a body formed by the UK Government to assess the suitability of vaccines for use in the UK population.

The Institute for Quantitative Health Science and Engineering at Michigan State University and Leica Microsystems, Inc., have combined efforts to establish the MSU IQ Leica Microsystems Center of Excellence.

West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.

GAAP loss per share was $0.04; Operating EPS¹ was $0.50 and excludes significant items in the quarter totaling $0.54 per share, primarily related to restructuring and asset-related charges, net of a gain on the divestiture of non-revenue generating rail infrastructure assets.

Tetra, Targeted Pharmaceutical and the George Mason University National Center for Biodefense and Infectious Diseases (NCBID) sign a research collaboration

Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, announced that it will release its financial results for the third quarter 2020 and business update on Thursday, October 29, 2020.

Experienced commercial leader solidifies Company’s management team as it integrates novel therapies with innovative drug delivery

Athenex, Inc. announced that it will release third quarter 2020 financial results on Thursday, November 5, 2020, before the market opens, and host a conference call and live audio webcast 8:00am Eastern Time to discuss financial results and provide a business update.

Growing Patent Estate Creates Value and Supports Key Combination Therapies